We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Strikes Deal With Shareholders on Celebrex, Bextra Class Action Suit
Pfizer Strikes Deal With Shareholders on Celebrex, Bextra Class Action Suit
Pfizer has reached a tentative settlement with shareholders to end a class action suit alleging the company minimized the cardiovascular risks of taking Celebrex and Bextra.